Document Detail

Oxidative modification of serum proteins in multiple sclerosis.
MedLine Citation:
PMID:  24036284     Owner:  NLM     Status:  Publisher    
Multiple sclerosis (MS) has been demonstrated to involve oxidative stress and augmented glycoxidation. In this study, several markers of protein oxidative damage and glycoxidation have been compared in relapsing remittent in 14 MS (RRMS) patients without immunomodifying treatment, 10 patients in clinical relapse, and clinically stable patient groups treated with interferon β 1a (18) , β 1b (19) and glatiramer acetate (GA; 6) in relation to healthy subjects (12). The glycophore content was increased in RRSM patients without treatment and in patients treated with GA. The level of advanced protein oxidation products (AOPP) was increased in RRSM patients without treatment and in patients with clinical relapse. The level of protein carbonyls was elevated in RRSM patients without treatment and in patients treated with interferon β 1b. The levels of dityrosine level and N'-formylkynureine were elevated in RRSM patients without treatment while serum protein thiol groups were decreased in RRSM patients in clinical relapse as well as RRMS treated with interferon β 1a. Several markers of protein modification showed correlation with the C-reactive protein level and white blood cell count, suggesting that oxidative protein modification are linked to the inflammatory processes in MS. Results of this study confirm the occurrence of protein oxidative and glycoxidative damage in MS and show that spectrophotometric and fluorimetric markers of this damage, especially the AOPP level, may be useful in monitoring oxidative stress in the course of therapy of MS.
Izabela Sadowska-Bartosz; Monika Adamczyk-Sowa; Sabina Galiniak; Sebastian Mucha; Krystyna Pierzchala; Grzegorz Bartosz
Related Documents :
24086434 - Extraocular muscle atrophy and central nervous system involvement in chronic progressiv...
23640624 - Health-related quality of life in patients on hemodialysis and peritoneal dialysis.
24815874 - Steatosis affects the performance of liver stiffness measurement for fibrosis assessmen...
24013704 - Prospective evaluation of cinefluoroscopy and chest radiography for riata lead defects:...
24703894 - Subcortical grey matter changes in untreated, early stage parkinson's disease without d...
8003784 - Frequency and significance of the major and minor features of hanifin and rajka among p...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-9-12
Journal Detail:
Title:  Neurochemistry international     Volume:  -     ISSN:  1872-9754     ISO Abbreviation:  Neurochem. Int.     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-9-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006959     Medline TA:  Neurochem Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Ltd. All rights reserved.
Department of Biochemistry and Cell Biology, University of Rzeszow, ul. Zelwerowicza 4, 35-601 Rzeszów, Poland. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lipid Inhibitors of High Affinity Glycine Transporters: Identification of a novel class of analgesic...
Next Document:  Angiocidin Induces Differentiation of Acute Myeloid Leukemia Cells.